Literature DB >> 21794765

[Defining remission in Rheumatoid Arthritis. New ACR/EULAR criteria].

Alejandro Balsa1.   

Abstract

Remission is the ideal treatment objective in the management of rheumatoid arthritis. To define remission, stringent criteria are needed which allow clinicians to assess the presence of active disease and which should be reliable enough to support therapeutic decisions. Currently there are many different remission classifications and none has been validated against important outcome measures such as the absence of progression of joint damage and disability. Recently, a subcommittee of the ACR and EULAR has proposed new criteria for remission based on a categorical classification and a composite score like SDAI allowing their use in clinical practice.
Copyright © 2010 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21794765     DOI: 10.1016/j.reuma.2010.10.006

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  3 in total

1.  Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study.

Authors:  Antonio Gomez-Centeno; Esteban Rubio-Romero; Juan Gabriel Ovalles; Sara Manrique-Arija; Sara Marsal-Barril; Juan Amarelo-Ramos; Javier Del Pino-Montes; Santiago Muñoz-Fernández; Sagrario Bustabad; Ceferino Barbazán-Álvarez
Journal:  Rheumatol Int       Date:  2019-08-08       Impact factor: 2.631

2.  Correlation between percentage of fat mass and level of disease activity in rheumatoid arthritis.

Authors:  Guadalupe Mendoza-Vázquez; Francisco Espinoza-Gómez; Alberto Daniel Rocha-Muñoz; Jorge I Gamez-Nava; Laura Gonzalez-Lopez; Mario Salazar-Paramo; Carlos Riebeling-Navarro; Javier Alejandro Aceves-Aceves; Sandra Guzmán-Silahua; Arnulfo Hernán Nava-Zavala
Journal:  SAGE Open Med       Date:  2022-03-21

3.  Value of Contrast-Enhanced Ultrasonography in Evaluating Rheumatoid Arthritis: Preliminary Research Based on an Animal Model.

Authors:  Yiran Gong; Yinan Huang; Yiming Su; Juxin He; Shuqiang Chen
Journal:  Med Sci Monit       Date:  2021-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.